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Incubation of human dermal ﬁbroblasts in keratinocyte-conditioned culture medium led to a 5.7-fold increase in the level of
matrix metalloproteinase-1. Virtually all of the matrix metalloproteinase-1 – inducing activity could be related to agonists
acting through members of the epidermal growth factor receptor family or to agonists acting through the interleukin-1
receptor. The same keratinocyte-conditioned medium also induced a modest increase in ﬁbroblast proliferation
(approximately 1.8-fold). Growth-stimulating activity could be attributed to epidermal growth factor receptor (but not
interleukin-1 receptor) function. In ﬁbroblasts exposed to keratinocyte-conditioned medium, mitogen-activated protein kinase
signalling through both the extracellular signal-related kinase pathway and p38 pathway occurred. When recombinant
epidermal growth factor or recombinant interleukin-1b were used as a control, they induced mitogen-activated protein kinase
signalling consistent with the combined effects of epidermal growth factor receptor – speciﬁc and interleukin-1 receptor –
speciﬁc agonists in keratinocyte-conditioned medium. Recombinant epidermal growth factor stimulated both matrix
metalloproteinase-1 induction and proliferation while recombinant interleukin-1b stimulated matrix metalloproteinase-1
elaboration but not ﬁbroblast growth. An inhibitor of extracellular signal-related kinase pathway signalling (U0126) blocked
induction of matrix metalloproteinase-1 production induced by keratinocyte-conditioned medium (as well as by epidermal
growth factor or interleukin-1b), and also inhibited proliferation. A p38 signalling inhibitor (SB203580) blocked matrix
metalloproteinase-1 elaboration induced by keratinocyte-conditioned medium or interleukin-1b, but did not inhibit matrix
metalloproteinase-1 elaboration or cell growth induced by epidermal growth factor. These data indicate that keratinocyte-
ﬁbroblast interactions are mediated by multiple stimulating agents acting on speciﬁc receptors to induce signalling through
different mitogen-activated protein kinase pathways leading to altered expression of key biological functions.
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Epithelial tumour cell penetration into the stroma during invasion
requires degradation of the basement membrane and the underly-
ing structural collagen. Matrix metalloproteinases (MMPs) with
collagenolytic activity are thought to be responsible for much of
the connective tissue damage that occurs during invasion (Bauer
et al, 1977; Goslen and Bauer 1986; Muller et al, 1993; Gray et
al, 1992; Varani et al, 2000). The tumour cells, themselves, are a
source of MMPs (Wright et al, 1994; Putnins et al, 1996), but a
variety of evidences suggests that cells of the stromal tissue
surrounding the tumour comprise a major source of tissue-destruc-
tive MMPs (Kataoka et al, 1993; Heppner et al, 1996; DeClerck,
2000).
We have utilised a human skin organ culture model to study the
process of stromal invasion by epithelial cells and the role of
MMPs in this process. In this invasion model, human skin is main-
tained in organ culture for a period of 8–12 days under serum-
free, growth factor-free conditions or in the presence of exogenous
growth-promoting factors. When the organ culture medium
contains no serum or exogenous growth factor, normal histological
structure and biochemical function are maintained (Varani et al,
1993, 1994). However, when epidermal growth factor (EGF) is
included in the organ culture medium, the epithelial cells undergo
proliferation. They grow down into the space occupied by the
dermis. Although, for the most part, separated from the stroma
by basement membrane, the basement membrane erodes in places
and epithelial cells invade the dermis at these sites (Fligiel and
Varani, 1993; Zeigler et al, 1996a). Invasion in this model is
accompanied by up-regulation of MMP-1 (interstitial collagenase)
and MMP-9 (92-kD gelatinase B), and is blocked by the inclusion
of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the culture
medium along with the exogenous growth factor (Varani et al,
1995; Zeigler et al, 1996b).
Efforts to understand how MMP-9 and MMP-1 are regulated
during invasion in this model have shown the following: MMP-9
is elaborated primarily in the epidermis (Varani et al, 1995; Zeigler
et al, 1996a); is up-regulated as a direct response of the epidermal
cells to the exogenous EGF (Zeigler et al, 1999); and depends on
signalling through mitogen activated protein kinase (MAPK) path-
ways (Zeigler et al, 1999). Speciﬁcally, signalling through both the
extracellular signal-related kinase (ERK) pathway and the jun-N-
terminal kinase (JNK) pathway occurs. This leads to formation
of active c-fos and c-jun and the combination of these elements
to form the AP-1 transcription complex. Interference with ERK
signalling using a chemical inhibitor or with JNK signalling
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www.bjcancer.comthrough use of a dominant-interfering mutant reduces formation
of the AP-1 complex and MMP-9 transcription. In contrast,
MMP-1 is primarily a dermal ﬁbroblast product. MMP-1 induction
reﬂects a ﬁbroblast response to factors elaborated within the
epidermis rather than a response to the exogenously-added EGF.
At least two different classes of epidermal-derived factors appear
to be important in promoting dermal MMP-1 production – i.e.,
factors that act through the interleukin-1 (IL-1) receptor, and
factors that bind to and activate the EGF receptor (Moon et al,
2001). Little is known about the intracellular signalling events that
are induced in ﬁbroblasts by epidermal keratinocytes to bring
about MMP-1 elaboration. The present study addresses this issue.
MATERIALS AND METHODS
Reagents
Human recombinant forms of EGF, heparin-binding EGF (HB-
EGF), IL-1b and IL-1 receptor antagonist were obtained from
R&D Systems (Minneapolis, MN, USA). U0126, a potent inhibitor
of ERK1,2 kinase activity (Favata et al, 1998) and SB203580, an
inhibitor of p38 kinase activity (Cuenda et al, 1995) were obtained
from Calbiochem (San Diego, CA, USA). PD169540, a potent inhi-
bitor of EGF receptor tyrosine kinase activity was a generous gift of
Drs WL Leopold and David Fry of Pﬁzer Global Research and
Development, Ann Arbor Laboratories, Ann Arbor, MI, USA.
PD169540 is an acrylamide-substituted 4-anilinopyrido[d]pyrimi-
dine designed to irreversibly alkylate Cys-773 within the ATP-
binding pocket of c-erbB1 and c-erbB2 (EGF receptor family
members) (Smaill et al, 2000).
Human epidermal keratinocytes in monolayer culture
Normal human epidermal keratinocytes were obtained from fore-
skin tissue (obtained at circumcision) as described previously
(Varani et al, 1994). They were maintained in monolayer culture
using Keratinocyte Growth Medium (KGM) (Clonetics, Inc., Walk-
ersville, MD, USA) as culture medium. KGM is a low-Ca
2+
(0.15 mM) modiﬁcation of MCDB-153 medium. It is supplemented
with a mixture of growth factors including 0.1 ng ml
71 EGF,
0.5 mgm l
71 insulin, and 2% bovine pituitary extract. Growth
was at 378C in an atmosphere of 95% air and 5% CO2. Cells were
sub-cultured by exposure to trypsin/EDTA and used at passage 2–
3. In some experiments, the HaCaT line of immortalised human
epidermal keratinocytes (Boukamp et al, 1988) was used in place
of normal keratinocytes. HaCaT cells were propagated in exactly
the same manner as low-passage keratinocytes, and used inter-
changeably with keratinocytes.
Culture ﬂuid was prepared from keratinocyte or HaCaT cultures
as follows: The cells were plated at 4610
4 cells per cm
2 of surface
area in 25-cm
2 or 75-cm
2 ﬂasks. KGM was used as culture
medium. When the cultures were approximately 75% conﬂuent,
the cells were washed twice in keratinocyte basal medium (KBM)
and incubated for 72 h in KBM supplemented with 1.4 mM
Ca
2+. KBM consists of the same basal formulation as KGM but
does not contain exogenous growth factors (EGF, insulin and
pituitary extract). At the end of the incubation period, the culture
ﬂuid was collected and separated from cells and debris by low-
speed centrifugation. The keratinocyte culture ﬂuid obtained in this
manner was used as a source of stimulating factor(s) for dermal
ﬁbroblast MMP-1 production.
Human dermal ﬁbroblasts in monolayer culture
Normal human dermal ﬁbroblasts were isolated from neonatal
foreskin as described previously (Varani et al, 1994). Fibroblasts
were grown in monolayer culture using Dulbecco’s Modiﬁed Mini-
mal Essential Medium supplemented with non-essential amino
acids and 10% foetal bovine serum (DMEM-FBS) as culture
medium. Fibroblasts were maintained at 378C in an atmosphere
of 95% air and 5% CO2. Cells were sub-cultured by exposure to
trypsin/EDTA and used at passage 2–3.
For assessment of MMP-1 production and for proliferation,
dermal ﬁbroblasts were plated at 2610
4 cells per cm
2 of surface
area in wells of a 24-well dish using DMEM-FBS as growth
medium. After allowing cells to attach, the medium was removed
and the cells washed twice in Ca
2+-supplemented KBM. The cells
were then incubated for 48 h in Ca
2+-supplemented KBM alone
or in a 50:50 (v v
71) mixture of Ca
2+ -supplemented KBM and
keratinocyte-conditioned medium. Additional reagents were added
as indicated in Results. At the end of the incubation period, the
cells were harvested by trypsinisation and enumerated using an
automated particle counter. Culture ﬂuid was clariﬁed by low-
speed centrifugation, following which it was assayed for MMP-1
as indicated below.
For assessment of signalling intermediates, cell extracts were
prepared by lysis of the ﬁbroblasts in buffer consisting of 20 mM
Tris-HCl (pH 7.4), 2 mM sodium vanadate, 2 mM 104 phosphate
substrate, 100 mM NaCl, 1% NP40 detergent, 0.5% sodium deox-
ycholate detergent, 25 mg ml
71 each aprotinin, leupeptin and
pepstatin and 2 mM each EDTA and EGTA. Lysis was performed
at 48C by scraping cells into the detergent-containing buffer and
then fragmenting cell debris by several passes through a 26-gauge
needle. Cell lysates were cleared by microcentrifugation at
12000 G followed by incubation at 48C for 25 min. The superna-
tant ﬂuid was recovered and protein concentration of the lysate
measured using the BioRad protein assay reagent (BioRad,
Hercules, CA, USA).
Substrate-embedded enzymography
SDS–PAGE substrate-embedded enzymography (zymography) was
used to identify enzymes with collagenase and gelatinase activities.
Assays were carried out exactly as described in a previous report
(Gibbs et al, 1999). Brieﬂy, denatured but non-reduced culture
ﬂuid samples were resolved in 7.5% SDS–PAGE gels prepared with
the added incorporation of gelatin (1 mg ml
71)o rb-casein
(1 mg ml
71) prior to casting. After electrophoresis, gels were
washed twice for 15 min in 50 mM Tris buffer containing 1 mM
Ca
2+, 0.5 mM Zn
2+ and 2.5% Triton X-100. The gels were then
incubated overnight in Tris buffer with 1% Triton X-100 and
stained the following day with Coumassie Brilliant Blue 250-R.
Following destaining, zones of enzyme activity were detected as
regions of negative staining against the dark background. The
zymograms were converted to negative images and digitised. Quan-
tiﬁcation was accomplished by determining the number of pixels in
the negative images. Volumes of 5–35 ml of undiluted culture ﬂuid
were normally used for these assays; zones of activity were propor-
tional to the quantity of culture ﬂuid used. Gelatin zymography is
useful for detection of MMP-2 (72-kD gelatinase A) in ﬁbroblast
cell culture ﬂuids. b-casein zymography is useful for detection of
MMP-1, which appears as a doublet in the 54-kD region of the
gel. The b-casein zymographic bands co-migrated with puriﬁed
MMP-1 as detected in Western blotting (Varani et al, 2000). Diges-
tion of native, ﬁbrillar type I collagen was observed in parallel with
expression of MMP-1, and blocked in the presence of TIMP-2 or
EDTA but not with a battery of serine proteinase inhibitors (Vara-
ni et al, 2000).
Western blot analysis of total and phosphorylated forms of
ERK and p38
Rabbit IgG antibodies to total and phosphorylated forms of ERK
1,2 and p38 were obtained from Cell Signaling (Beverly, MA,
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British Journal of Cancer (2002) 87(4), 457–464 ã 2002 Cancer Research UKUSA). Antibodies to total and phosphorylated forms of c-jun were
obtained from Signal Transduction Laboratories (Lexington, KY,
USA). Equivalent amounts of ﬁbroblast extract (40 mg lane
71)
were resolved by SDS–PAGE (12%) and transferred to nitrocellu-
lose membranes by electroblotting using a BioRad mini transfer
blotting apparatus. Membranes were then blocked in Ca
2+- and
Mg
2+-free Tris-buffered saline (TBS) containing 5% Blotto.
Membranes were then treated with antibodies to total or phos-
phorylated forms of the signalling intermediates (1:400–1:1000
dilutions) in TBS containing 0.5% Blotto and 0.1% Tween for
1 h. Following several rinses in TBS with 0.1% Tween, the
membrane-bound antibodies were reacted with horseradish perox-
idase-conjugated goat anti-rabbit antibody at 1:2000 dilution for
1 h. Protein-antibody complexes were detected by enhanced chemi-
luminescence (Cell Signaling) and visualised on light-sensitive
autoradiographic ﬁlm (Amersham, Pharmacia, London, UK). Digi-
tisation and quantitation was performed as with zymography
except that negative images were not constructed.
RESULTS
Epidermal keratinocyte stimulation of ﬁbroblast MMP-1
elaboration and proliferation: Effects of ERK and p38
inhibitors
Human dermal ﬁbroblasts were exposed to 72-h keratinocyte-
conditioned medium and incubated for 2 days. At the end of the
incubation period, MMP-1 production and proliferation were
assessed. Consistent with our recent ﬁndings (Moon et al, 2001),
there was a greater than ﬁve-fold stimulation of MMP-1 produc-
tion and an approximately two-fold increase in growth. Effects of
two MAPK inhibitors – i.e., U0126 and SB203580 – on MMP-1
elaboration and growth were assessed. In the presence of 10 mM
U0126, MMP-1 production was reduced by 88% and ﬁbroblast
growth was reduced by 95% (Figures 1A and 2A). The effects of
U0126 on both biological responses were dose responsive. Activity
(albeit reduced) was observed at a concentration of 1 mM.
SB203580 also effectively blocked MMP-1 elaboration induced by
keratinocyte-conditioned medium (84% inhibition at 15 mM), but
this agent had no effect on the ﬁbroblast proliferative response
(Figure 2A). The ﬁbroblast response to SB203580 was also dose-
responsive, with activity seen at 1.5 mM. In contrast to the results
with MMP-1, there was virtually no change in the level of
MMP-2 in response to keratinocyte-conditioned medium and no
effect with either U0126 or SB203580 (Figure 1, insert).
In a recent study it was demonstrated that ligand(s) which act
through the EGF receptor and ligand(s) which act through the IL-1
receptor could together account for virtually all of the MMP-1 –
inducing activity in keratinocyte culture ﬂuid while EGF receptor
agonists by themselves accounted for proliferation-inducing activity
(Moon et al, 2001). We therefore utilised recombinant ligands for
these receptors for comparative purposes. As shown in Figures 1B
and 2B, EGF (10 ng ml
71) induced both MMP-1 elaboration and
proliferation in ﬁbroblasts. In comparison to keratinocyte culture
ﬂuid, MMP-1 – inducing activity of EGF was low (2.3-fold increase).
Proliferation-inducing activity of puriﬁed recombinant EGF was
comparable to that of keratinocyte culture ﬂuid. Figures 1B and 2B
also demonstrate that in the presence of U0126 (10 mM), EGF-
induced MMP-1 production was reduced by 54% while EGF-induced
proliferation was reduced by 34%. SB203589 (15 mM) had minimal
inhibitory effect on MMP-1 production, and actually enhanced
proliferation in response to EGF (Figures 1B and 2B).
Figures 1C and 2C show results from studies in which IL-1b
(1 ng ml
71) was used to stimulate ﬁbroblast production of MMP-
1 and ﬁbroblast proliferation. In the presence of IL-1b, there was a
substantial induction of MMP-1 (5.3-fold), comparable to that seen
in the presence of keratinocyte-conditioned medium. In contrast, IL-
1b failed completely to stimulate ﬁbroblast proliferation. In the
presence of U0126, IL-1b – stimulated MMP-1 production was
inhibited by 49%. In the presence of SB203580, 66% inhibition
was observed. When proliferation rather than MMP-1 production
was assessed, the presence of U0126 had no effect on the (lack of)
response to IL-1b. Treatment with SB203580 along with IL-1b,
however, actually enhanced proliferation slightly.
ERK 1,2 phosphorylation in ﬁbroblasts stimulated by 72-h
keratinocyte-conditioned medium: comparison with EGF-
and IL-1b -induced phosphorylation
Figure 3 demonstrates changes in ERK 1,2 phosphorylation at 30
and 60 min in ﬁbroblasts exposed to conditioned medium from
72-h keratinocyte cultures. Increased phosphorylation was observed
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Figure 1 Fibroblast production of MMP-1 in response to stimulation by
(A) keratinocyte-conditioned medium, (B) EGF and (C) IL-1b. Fibroblasts
were exposed to culture medium alone or to a 50:50 mixture of culture
medium and keratinocyte-conditioned medium. U0126 (10 mM)o r
SB203580 (15 mM) was included as indicated. At the end of the 2-day in-
cubation period, MMP-1 was assessed by b-casein zymography. Quantita-
tion was accomplished by densitometry scanning as described in the
Materials and Methods section. Values shown are means and standard de-
viations based on four separate experiments. The insert shows a b-casein
zymogram from one experiment. Lane 1 demonstrates MMP-1 levels (54
kD) in control ﬁbroblast culture ﬂuid; Lane 2 shows increased enzyme pro-
duced by ﬁbroblasts exposed to keratinocyte-conditioned medium. Lanes
3 and 4 show the effects of U0126 and SB203580, respectively, on up-
regulated enzyme production. A gelatin zymogram is shown for control.
Neither inhibitor inﬂuenced expression of MMP-2 (72 kD).
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(4), 457–464as early as 10 min after stimulation (earliest time-point examined;
not shown), reached a maximum at 30 min and decreased to
approximately 50% of the maximum value by 60 min. Changes
in ERK 1,2 phosphorylation induced by EGF and IL-1b are shown
for comparison. In the presence of EGF, ERK 1,2 phosphorylation
was increased at the 30-min time-point and remained elevated
through 60 min (longest time-point examined) (Figure 3).
Although EGF was used as the EGF receptor agonist in most
experiments, we also conﬁrmed that a similar proﬁle of ERK 1,2
phosphorylation occurred in the presence of HB-EGF. That is, at
10 ng ml
71, stimulation was seen at 30-min and remained elevated
(approximately 50% of maximum) through at least 60 min (data
not shown). IL-1b also induced ERK 1,2 phosphorylation.
Enhanced phosphorylation was observed at 30 min. However, by
60 min, the level of phosphorylated ERK 1,2 had decreased to
below baseline values. Under none of the conditions examined
was there a measurable change in steady-state (total) ERK 1,2
protein (Figure 3).
The inhibitor U0126 was used in an effort to block ERK 1,2 phos-
phorylation. At a concentration of 10 mM, U0126 suppressed ERK
1,2 phosphorylation induced by keratinocyte-conditioned medium
to below baseline levels (Table 1). Substantial inhibition was also
observed when either EGF or IL-1b was used to induce ERK phos-
phorylation (Table 1).
p38 phosphorylation in ﬁbroblasts stimulated by 72-h
keratinocyte-conditioned medium: comparison with
phosphorylation induced by EGF- and IL-1b
Figure 4 demonstrates p38 phosphorylation in ﬁbroblasts under the
same conditions as assessed with ERK 1,2. In the presence of 72-h
keratinocyte culture ﬂuid, p38 phosphorylation was strongly
induced at 30 min. However, stimulation was transient. By
60 min, phosphorylation of p38 was decreased by 71% from the
value seen at 30 min. When EGF was examined, p38 phosphoryla-
tion was not induced at either 30 or 60 min. In contrast, when IL-
1b was used as the stimulus, the p38 phosphorylation pattern
resembled that induced by keratinocyte culture ﬂuid. Phosphoryla-
tion was induced at 30 min but had decreased to almost baseline
level by 60 min. Under none of the conditions examined was there
a measurable change in steady-state p38 protein (Figure 4).
Additional experiments were conducted in which an IL-1 recep-
tor antagonist and a potent EGF receptor tyrosine kinase
antagonist (PD169540) were examined for ability to modulate
p38 phosphorylation induced by keratinocyte culture ﬂuid. In the
presence of IL-1 receptor antagonist (50 mgm l
71), p38 phosphor-
ylation was inhibited by 80% at 30 min and virtually 100% at
60 min. Not surprising in light of the failure of EGF to induce
p38 phosphorylation, PD169540 (1 mM) was completely ineffective
in preventing p38 phosphorylation (Figure 5).
In the next set of experiments, effects of SB203580 on p38 phos-
phorylation induced by keratinocyte culture ﬂuid was assessed.
Consistent with the ﬁndings presented in Figure 4, p38 phosphor-
ylation was increased at 30 min under control conditions (i.e., in
the presence of keratinocyte-conditioned medium) and then
decreased almost to baseline by 60 min. In the presence of both
the keratinocyte culture ﬂuid and the inhibitor, the level of phos-
phorylation seen at 30 min was increased slightly over that seen
with culture ﬂuid alone. More impressively, the decrease seen at
60 min in the presence of culture ﬂuid was substantially inhibited
in the presence of SB203580 (Figure 6). Similar results were
observed when IL-1b was used as the stimulus in place of keratino-
cyte culture ﬂuid (Figure 6).
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Table 1 Effects of U0126 on ERK 1,2 phosphorylation induced by kera-
tinocyte-conditioned medium, EGF and IL-1b
ERK 1,2 phosphorylation (Fold-Induction)
Treatment group 30 min 60 min
KC-conditioned medium 3.1+0.1 3.5+0.5
+U0126 0.6+0.4 0.5+0.4
EGF 2.2 3.0
+U0126 0.5 0.4
IL-1b 3.4 0.3
+U0126 0.7 0.2
Fibroblasts were exposed for 30 or 60 min to culture medium alone or to a 50:50
mixture of culture medium and keratinocyte-conditioned medium with or without
10 mM U0126. EGF (10 ng ml
71) and IL-1b (1 ng ml
71) served as controls. At
the end of the incubation period, extracts were prepared and assayed for phos-
pho-ERK 1,2 expression as described in the Materials and Methods section. Values
shown are expressed as fold-induction relative to the level detected in cells exposed
to culture medium alone. Values for keratinocyte-conditioned medium (KC-condi-
tioned medium) are presented as averages of two experiments+the differences
between individual values and averages.
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Figure 2 Fibroblast proliferation in response to stimulation by (A) ker-
atinocyte-conditioned medium, (B) EGF and (C) IL-1b. Fibroblasts were
exposed to culture medium alone or to a 50:50 mixture of culture med-
ium and keratinocyte-conditioned medium. U0126 (10 mM) or SB203580
(15 mM) was included as indicated. At the end of the 2-day incubation per-
iod, cell number was assessed as described in the Materials and Methods
section. Values shown are means and standard deviations based on four
separate experiments, each with duplicate or triplicate samples.
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stimulate c-jun phosphorylation in the absence and presence of
SB203580. In the absence of the inhibitor, there was an approxi-
mately 3.6-fold increase in phosphorylation at 30 min, which
decreased to 1.5-fold at 60 min. The presence of SB203580 had
virtually no effect at 30 min, but completely inhibited the decrease
at 60 min (Figure 7). The level of c-jun steady-state protein
remained constant (Figure 7).
DISCUSSION
MMPs are thought to play a major role in tissue destruction asso-
ciated with tumour invasion (reviewed in: Stetler-Stevenson et al,
1993; Stamenkovic, 2000; Herouy, 2001). Utilising an organ culture
model of epithelial cell invasion in skin, we have demonstrated that
stromal invasion in this model was accompanied by the up-regula-
tion of MMP-9 and MMP-1 and inhibited in the presence of
exogenous TIMP-2 (Varani et al, 1995; Zeigler et al, 1996b).
MMP-9 was elaborated in the epidermis as a direct response to
the exogenous growth factors used to stimulate invasion. In
contrast, MMP-1 was produced largely in the stroma. Induction
of this enzyme occurred as a response to factors elaborated by
the epidermis. At least two distinct epithelial cell factors – one,
a ligand for the EGF receptor, and the other an agonist for the
IL-1 receptor – appeared to be responsible for enzyme induction
(Moon et al, 2001). In the present study we have examined MAPK
signalling events that underlie MMP-1 induction in ﬁbroblasts
following exposure to conditioned medium from keratinocyte
cultures. To summarise, activation of both ERK and p38 pathways
occurs in ﬁbroblasts exposed to keratinocyte-conditioned medium,
and both pathways contribute to enzyme induction. Several impor-
tant issues can be addressed relative to these ﬁndings.
One is the relationship between MAPK signalling events trig-
gered by keratinocyte-conditioned medium and MMP-1
induction by the same factors. Our data indicate that activation
of ERK 1,2 by keratinocyte-conditioned medium reﬂects the
summation of action of ligands for both EGF receptor and IL-1
receptor, while p38 activation is mediated primarily (if not exclu-
sively) by IL-1 receptor agonists. This is based on the similarity of
phosphorylation patterns seen at 30 and 60 min after exposure of
the cells to either keratinocyte-conditioned medium or to proto-
type ligands for the two receptors (i.e., EGF and IL-1b)a s
indicated in Figures 3 and 4. Consistent with this, the ERK path-
way inhibitor U0126 strongly inhibited MMP-1 production in
ﬁbroblasts exposed to keratinocyte culture medium, and concomi-
tantly reduced MMP-1 production in ﬁbroblasts exposed to either
EGF or IL-1b. The p38 pathway inhibitor SB203580 also inhibited
MMP-1 induction by keratinocyte-conditioned medium. This inhi-
bitor blocked MMP-1 production in response to IL-1b, but in
contrast to U0126, had no effect of MMP-1 production following
EGF stimulation. Taken together, these data indicate that EGF-like
ligands induce MMP-1 production in ﬁbroblasts by acting through
the ERK pathway (independent of p38). In contrast, the IL-1 recep-
tor agonist(s) appear to stimulate MMP-1 production by
concomitantly signalling through both ERK and p38 pathways.
It should be noted that while the actual keratinocyte-derived
ligands for the EGF and IL-1 receptors were not identiﬁed in this
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Figure 4 p38 phosphorylation in ﬁbroblasts in response to stimulation
by keratinocyte-conditioned medium, EGF and IL-1b. Fibroblasts were ex-
posed for 30 or 60 min to culture medium alone or to a 50:50 mixture of
culture medium and keratinocyte-conditioned medium. At the end of the
incubation period, extracts were prepared and assayed for phospho-p38
expression as described in the Materials and Methods section. Values
shown are expressed as fold-induction relative to the level detected in cells
exposed to culture medium alone. Values are means and standard devia-
tions based on n=6 separate experiments for keratinocyte-conditioned
medium and n=5 for EGF and IL-1b. The insert demonstrates a Western
blot from one experiment. To: p38 phosphorylation in an extract from cells
exposed to culture medium alone at time-zero; Ctrl: p38 phosphorylation
in extracts from ﬁbroblast exposed to culture medium alone at each time-
point. p38-P=phosphorylated p38. p38-SS=total p38 protein.
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Figure 3 ERK 1,2 phosphorylation in ﬁbroblasts in response to stimula-
tion by keratinocyte-conditioned medium, EGF and IL-1b. Fibroblasts were
exposed for 30 or 60 min to culture medium alone or to a 50:50 mixture
of culture medium and keratinocyte-conditioned medium. At the end of
the incubation period, extracts were prepared and assayed for phospho-
ERK expression as described in the Materials and Methods section. Values
shown are expressed as fold-induction relative to the level detected in cells
exposed to culture medium alone. Values are means and standard devia-
tions based on n=6 separate experiments for keratinocyte-conditioned
medium and n=5 for EGF and IL-1b. The insert demonstrates a Western
blot from one experiment. To: ERK 1,2 phosphorylation in an extract from
cells exposed to culture medium alone at time-zero; Ctrl: ERK 1,2 phos-
phorylation in extracts from cells exposed to control medium alone at each
time-point. ERK-P=phosphorylated ERK 1,2. ERK-SS=total ERK 1,2 protein.
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the EGF receptor while IL-1b is the major keratinocyte ligand for
the IL-1 receptor. Keratinocytes produce several EGF receptor
agonists, but of these, only HB-EGF is strongly up-regulated in
organ-cultured skin (Stoll et al, 1997). Furthermore, it was shown
in a recent study that epidermal hyperplasia in organ-cultured skin
could be inhibited with an antibody to HB-EGF (Varani et al,
2001). IL-1b is likely to be the major agonist for the IL-1 receptor
because although both IL-1a and IL-1b are elaborated by keratino-
cytes, the b form is the major isoform secreted into the culture
medium while the IL-1a remains largely cell-associated (Maas-
Szabowski et al, 1999; Maas-Szabowski et al, 2000).
While ligands for both EGF and IL-1 receptors participate in the
induction of MMP-1 elaboration, the data suggest that ligands
acting through the IL-1 receptor provide the predominant stimu-
lus. In the presence of EGF, a 2.3-fold induction of MMP-1 was
seen while in the presence of IL-1b, induction was 5.5-fold. Both
EGF (as well as HB-EGF) and IL-1b were examined over a wide
range of concentrations and these were the maximal values
obtained. More importantly, it was demonstrated in a recent study
that a potent EGF receptor tyrosine kinase inhibitor completely
blocked MMP-1 induction by EGF but was only modestly effective
in blocking stimulation by keratinocyte-conditioned medium. In
contrast, IL-1 receptor antagonist was highly-effective in blocking
MMP-1 induction by either IL-1b or keratinocyte culture ﬂuid
(Moon et al, 2001).
A corollary issue is the relative contribution of each of the two
signalling pathways to MMP-1 induction and the possible interac-
tion between the two. Greatly reduced MMP-1 production in the
presence of either the ERK pathway inhibitor or the p38 pathway
inhibitor strongly suggests that signalling through both MAPK
pathways is required for induction of MMP-1 by keratinocyte-
conditioned medium. The contribution of EGF (acting through
the ERK pathway) appears to be independent of p38, based on
the lack of effect of the p38 inhibitor in preventing EGF-induced
MMP-1 up-regulation. The fact that c-jun is still phosphorylated
(and presumably activated) in the presence of SB203580, provides
a p38-independent path to the formation of the AP-1 transcription
complex (Zeigler et al, 1999). This does not appear to be the case
with the component of stimulation due to IL-1b. Stimulation of
MMP-1 production via IL-1 receptor activation can be blocked
by inhibiting either ERK or p38 signalling. Since almost identical
results were achieved when either keratinocyte-conditioned
medium or recombinant IL-1b was used as agonist, the presump-
tion is IL-1 receptor activation is the major pathway leading to
MMP-1 up-regulation and that signalling through both ERK and
p38 pathways is required for maximal stimulation via this receptor.
The ﬁndings presented here are of interest in regard to what has
been seen in other cell types or in ﬁbroblasts stimulated with other
agonists. Recent studies have shown that in human dermal ﬁbro-
blasts, MMP-1 – inducing agents as diverse as okadaic acid,
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Figure 6 Effects of SB203580 on p38 phosphorylation induced by ker-
atinocyte-conditioned medium or IL-1b. Fibroblasts were exposed for 30
or 60 min to culture medium alone or to a 50:50 mixture of culture med-
ium and keratinocyte-conditioned medium with or without 15 mM
SB203580. At the end of the incubation period, extracts were prepared
and assayed for phospho-p38 expression as described in the Materials
and Methods section. Values shown are expressed as fold-induction rela-
tive to the level detected in cells exposed to culture medium alone. The
insert demonstrates a Western blot from one experiment. p38-P=phos-
phorylated p38. p38-SS=total p38 protein.
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keratinocyte-conditioned medium. Fibroblasts were exposed for 30 or
60 min to culture medium alone or to a 50:50 mixture of culture medium
and keratinocyte-conditioned medium with or without 50 mgm l
71 IL-1 re-
ceptor antagonist or 1 mM PD169540. At the end of the incubation period,
extracts were prepared and assayed for phospho-p38 expression as de-
scribed in the Materials and Methods section. Values shown are expressed
as fold-induction relative to the level detected in cells exposed to culture
medium alone. The insert demonstrates a Western blot from one experi-
ment. p38-P=phosphorylated p38. p38-SS=total p38 protein.
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are susceptible to inhibition of either ERK or p38 signalling (Lim et
al, 1998; Reunanen et al, 1998; Westermarck et al, 1998). In
contrast, MMP-1 induced by basic ﬁbroblast growth factor is
susceptible to ERK inhibition but not to inhibition of p38 signal-
ling (Brauchle et al, 2000). Taken together with our current
ﬁndings, this suggests that ‘classical’ growth factors may provide
a route to MMP-1 up-regulation not shared with many other
agonists. Our own past studies with MMP-9 induction in keratino-
cytes is consistent with this. In those studies, it was observed that
EGF-induced signalling occurred through ERK and JNK pathways
without signiﬁcant activation of p38 (Zeigler et al, 1999). In kera-
tinocytes, MMP-9 production was blocked with an ERK pathway
inhibitor (PD98059) or when a dominant interfering JNK mutant
was introduced into the cells.
Another issue is the relationship between MMP-1 induction in
ﬁbroblasts exposed to keratinocyte-conditioned culture medium
and the concomitant induction of ﬁbroblast proliferation. Fibro-
blast proliferation was induced to a similar extent by
keratinocyte-conditioned medium and exogenous EGF, but there
was no stimulation by IL-1b. The ERK pathway inhibitor reduced
cell growth due to either stimulus while the p38 pathway inhibitor
was without effect. These data suggest that ﬁbroblast proliferation
in response to keratinocyte culture ﬂuid reﬂects growth factor acti-
vation of the ERK pathway. This is consistent with previous
ﬁndings in other cell types (Dimon-Gadal et al, 1998; Zeigler et
al, 1999; Chung et al, 2000). How ERK promotes ﬁbroblast prolif-
eration is not fully understood. The proliferative response may
reﬂect activation of the cell cycle progression factors such as cyclin
D2 by ERK (Chung et al, 2000). Of interest, ﬁbroblasts treated with
the p38 inhibitor had a small but reproducible increase in growth
regardless of whether the cells had been stimulated with either
keratinocyte-conditioned medium or EGF. Even in the presence
of IL-1b, where there was no proliferation in the absence of inhi-
bitor (Proliferation index of 0.98), there was a slight positive
response in the presence of SB203580 (Proliferation index of
1.26). How this is brought about is not known. Perhaps signalling
through p38 results in the production of growth-inhibiting mole-
cules. Alternatively, signalling through p38 may simply provide
more substrate for interaction with down-stream elements of
ERK, which may, in turn, utilise activated ERK and prevent it
actions elsewhere. Additional experiments will be needed to fully
address this and other possibilities.
In summary, while no in vitro culture system can fully mimic
what occurs in vivo, these data allow one to suggest that keratino-
cyte-ﬁbroblast interactions are mediated by multiple stimulating
agents acting on speciﬁc receptors to induce signalling through
different MAPK pathways in order to jointly alter expression of
key biological functions.
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